The use of trifluoromethyl tubercidin as a novel treatment of influenza in an overwhelmed health care setting: a correspondence
Syeda Shahnoor(Dow University of Health Sciences), Aymar Akilimali(Roslin Institute), Aimen Waqar Khan(Ayub Medical College), Mutiu Olamide Abdulrahman(Norfolk and Norwich University Hospital), Alishba Fatima(Dow University of Health Sciences), Malik Olatunde Oduoye(Ahmadu Bello University), Abdul Moiz Khan(Ayub Medical College)
Cited by 2
Related Papers
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Impacts of the advancement in artificial intelligence on laboratory medicine in low‐ and middle‐income countries: Challenges and recommendations—A literature review
|Health Science Reports|2024|62
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29